Certor Sports keeps Vicis R&D in Seattle, adding 4–5 jobs as it opens 230,000 sq ft HQ in Indiana
Vicis, the Seattle-based high-tech helmet maker bought out of receivership by Innovatus Capital Partners and now owned by Certor Sports, will keep its Seattle R&D office (10 employees) and add 4–5 hires while Certor opens a 230,000 sq ft headquarters in Indiana. Vicis raised over $85 million, drew NFL investor support, but collapsed in 2019 before being acquired for under $3 million and partially restarted by former staff.
AI2 Adds Bioengineer Jenny Cronin to Incubator; Icosavax Names Bekiroglu, Russo and Two Board Members; Proprio’s CMO Browd Expands Role
AI2 hired bioengineer Jenny Cronin as a principal for its startup incubator, bringing experience from s2s Public Relations, NanoString, and a UW bioengineering Ph.D.; AI2 has incubated startups like Ozette, Modulus and MajorBoost. Seattle biotech Icosavax named Elizabeth Bekiroglu general counsel, Thomas Russo CFO, and added Heidi Kunz and Ann Veneman to its board; pediatric neurosurgeon Samuel Browd is taking partial leave from UW/Seattle Children’s to expand as CMO of surgical tech startup Proprio.
Proprio raises $23M Series A led by DCVC to commercialize 3D "X‑ray‑like" surgical navigation system
Seattle startup Proprio raised $23 million in a Series A led by DCVC to develop a hardware‑software surgical navigation system that fuses real-time camera views with preoperative imaging to give surgeons a 3D “X‑ray‑like” view without radiation.
See all 9 stories, episodes and videos about Samuel Browd.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
Organizations
-
University of Washington Professor of Neurological Surgery · current
-
VICIS Executive Officer, Director 2016, Co-founder · past
-
Seattle Children's Hospital Sports Concussion Program Medical Director · past